DOC2A Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q14183 |
---|---|
Clone Names | 100405154 |
Gene ID | 8448 |
---|---|
Other Names | Double C2-like domain-containing protein alpha, Doc2, Doc2-alpha, DOC2A |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | DOC2A |
---|---|
Function | Calcium sensor which most probably regulates fusion of vesicles with membranes. Binds calcium and phospholipids. May be involved in calcium dependent neurotransmitter release through the interaction with UNC13A. May be involved in calcium-dependent spontaneous release of neurotransmitter in absence of action potentials in neuronal cells. Regulates Ca(2+)-dependent secretory lysosome exocytosis in mast cells. |
Cellular Location | Lysosome. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Peripheral membrane protein. Synapse, synaptosome |
Tissue Location | Predominantly expressed in brain. Also expressed in testis. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
There are at least two protein isoforms of the Double C2protein, namely alpha (DOC2A) and beta (DOC2B), which contain twoC2-like domains. DOC2A and DOC2B are encoded by different genes;these genes are at times confused with the unrelated DAB2 genewhich was initially named DOC-2. DOC2A is mainly expressed in brainand is suggested to be involved in Ca(2+)-dependentneurotransmitter release.
References
Shimada, M., et al. Hum. Genet. 128(4):433-441(2010)Glessner, J.T., et al. Proc. Natl. Acad. Sci. U.S.A. 107(23):10584-10589(2010)Guilmatre, A., et al. Arch. Gen. Psychiatry 66(9):947-956(2009)Kumar, R.A., et al. PLoS ONE 4 (2), E4582 (2009) :Higashio, H., et al. J. Immunol. 180(7):4774-4784(2008)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.